Relmada Therapeutics Q1 EPS $(0.22) Misses $(0.20) Estimate
Benzinga Newsdesk 5 months ago
EarningsEarnings MissesNews
Relmada Therapeutics (NASDAQ:RLMD) reported quarterly losses of $(0.22) per share which missed the analyst consensus estimate of $(0.20) by 10 percent. This is a 62.07 percent increase over losses of $(0.58) per share
Relmada Therapeutics (NASDAQ:RLMD) reported quarterly losses of $(0.22) per share which missed the analyst consensus estimate of $(0.20) by 10 percent. This is a 62.07 percent increase over losses of $(0.58) per share from the same period last year.